Ameriprise Financial Inc. increased its stake in Eastman Chemical Company (NYSE:EMN - Free Report) by 33.1% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 575,191 shares of the basic materials company's stock after buying an additional 142,897 shares during the quarter. Ameriprise Financial Inc. owned about 0.50% of Eastman Chemical worth $50,700,000 as of its most recent filing with the SEC.
A number of other large investors have also modified their holdings of EMN. GAMMA Investing LLC grew its stake in Eastman Chemical by 11,261.1% during the 1st quarter. GAMMA Investing LLC now owns 476,939 shares of the basic materials company's stock valued at $42,023,000 after purchasing an additional 472,741 shares in the last quarter. Nuveen LLC acquired a new stake in Eastman Chemical during the 1st quarter valued at approximately $26,289,000. Dimensional Fund Advisors LP grew its stake in Eastman Chemical by 8.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,588,331 shares of the basic materials company's stock valued at $228,042,000 after purchasing an additional 202,740 shares in the last quarter. Albar Capital Partners LLP acquired a new stake in Eastman Chemical during the 4th quarter valued at approximately $12,930,000. Finally, Royal Bank of Canada grew its stake in Eastman Chemical by 42.3% during the 4th quarter. Royal Bank of Canada now owns 467,787 shares of the basic materials company's stock valued at $42,717,000 after purchasing an additional 139,099 shares in the last quarter. Institutional investors and hedge funds own 83.65% of the company's stock.
Eastman Chemical Stock Performance
Eastman Chemical stock traded down $0.92 during mid-day trading on Tuesday, hitting $69.42. 1,358,744 shares of the company's stock traded hands, compared to its average volume of 1,377,664. The firm has a 50 day moving average price of $72.17 and a 200 day moving average price of $79.79. The company has a quick ratio of 0.78, a current ratio of 1.68 and a debt-to-equity ratio of 0.81. The company has a market cap of $7.97 billion, a PE ratio of 9.75, a price-to-earnings-growth ratio of 6.72 and a beta of 1.25. Eastman Chemical Company has a one year low of $56.78 and a one year high of $114.50.
Eastman Chemical (NYSE:EMN - Get Free Report) last announced its earnings results on Thursday, July 31st. The basic materials company reported $1.60 earnings per share for the quarter, missing the consensus estimate of $1.72 by ($0.12). The business had revenue of $2.29 billion for the quarter, compared to the consensus estimate of $2.32 billion. Eastman Chemical had a net margin of 8.96% and a return on equity of 15.24%. The firm's revenue was down 3.2% on a year-over-year basis. During the same period in the previous year, the firm earned $2.15 EPS. Eastman Chemical has set its Q3 2025 guidance at 1.250-1.250 EPS. On average, equities analysts forecast that Eastman Chemical Company will post 8.55 EPS for the current year.
Eastman Chemical Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, October 7th. Shareholders of record on Monday, September 15th will be paid a dividend of $0.83 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $3.32 annualized dividend and a yield of 4.8%. Eastman Chemical's payout ratio is presently 46.63%.
Analysts Set New Price Targets
Several research analysts have recently commented on the company. Citigroup decreased their target price on Eastman Chemical from $90.00 to $68.00 and set a "buy" rating for the company in a research report on Monday, August 4th. UBS Group decreased their target price on Eastman Chemical from $107.00 to $101.00 and set a "buy" rating for the company in a research report on Wednesday, July 9th. Wells Fargo & Company decreased their target price on Eastman Chemical from $90.00 to $70.00 and set an "overweight" rating for the company in a research report on Monday, August 4th. Royal Bank Of Canada decreased their target price on Eastman Chemical from $91.00 to $74.00 and set an "outperform" rating for the company in a research report on Tuesday, August 5th. Finally, The Goldman Sachs Group decreased their target price on Eastman Chemical from $87.00 to $65.00 and set a "neutral" rating for the company in a research report on Thursday, August 7th. Eight investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $87.00.
Read Our Latest Stock Analysis on Eastman Chemical
About Eastman Chemical
(
Free Report)
Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids.
Read More

Before you consider Eastman Chemical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eastman Chemical wasn't on the list.
While Eastman Chemical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.